Literature DB >> 33584546

Epigenetic Memory: Lessons From iPS Cells Derived From Human β Cells.

Shimon Efrat1.   

Abstract

Incomplete reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) may be responsible for the heterogeneity in differentiation capacity observed among iPSC lines. It remains unclear whether it results from stochastic reprogramming events, or reflects consistent genetic or cell-of-origin differences. Some evidence suggests that epigenetic memory predisposes iPSCs to enhanced differentiation into the parental cell type. We investigated iPSCs reprogrammed from human pancreatic islet β cells (BiPSCs), as a step in development of a robust differentiation protocol for generation of β-like cells. BiPSCs derived from multiple human donors manifested enhanced and reproducible spontaneous and induced differentiation towards insulin-producing cells, compared with iPSCs derived from isogenic non-β-cell types and fibroblast-derived iPSCs (FiPSCs). Genome-wide analyses of open chromatin in BiPSCs and FiPSCs identified thousands of differential open chromatin sites (DOCs) between the two iPSC types. DOCs more open in BiPSCs (Bi-DOCs) were significantly enriched for known regulators of endodermal development, including bivalent and weak enhancers, and FOXA2 binding sites. Bi-DOCs were associated with genes related to pancreas development and β-cell function. These studies provide evidence for reproducible epigenetic memory in BiPSCs. Bi-DOCs may provide clues to genes and pathways involved in the differentiation process, which could be manipulated to increase the efficiency and reproducibility of differentiation of pluripotent stem cells from non-β-cell sources.
Copyright © 2021 Efrat.

Entities:  

Keywords:  ATAC-seq; Epigenetic memory; Foxa2; Islet β Cells; pluripotent stem cell differentiation

Mesh:

Year:  2021        PMID: 33584546      PMCID: PMC7874102          DOI: 10.3389/fendo.2020.614234

Source DB:  PubMed          Journal:  Front Endocrinol (Lausanne)        ISSN: 1664-2392            Impact factor:   5.555


  27 in total

1.  Differentiation of human limbal-derived induced pluripotent stem cells into limbal-like epithelium.

Authors:  Dhruv Sareen; Mehrnoosh Saghizadeh; Loren Ornelas; Michael A Winkler; Kavita Narwani; Anais Sahabian; Vincent A Funari; Jie Tang; Lindsay Spurka; Vasu Punj; Ezra Maguen; Yaron S Rabinowitz; Clive N Svendsen; Alexander V Ljubimov
Journal:  Stem Cells Transl Med       Date:  2014-07-28       Impact factor: 6.940

2.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

3.  Generation of functional human pancreatic β cells in vitro.

Authors:  Felicia W Pagliuca; Jeffrey R Millman; Mads Gürtler; Michael Segel; Alana Van Dervort; Jennifer Hyoje Ryu; Quinn P Peterson; Dale Greiner; Douglas A Melton
Journal:  Cell       Date:  2014-10-09       Impact factor: 41.582

4.  Charting cellular identity during human in vitro β-cell differentiation.

Authors:  Adrian Veres; Aubrey L Faust; Henry L Bushnell; Elise N Engquist; Jennifer Hyoje-Ryu Kenty; George Harb; Yeh-Chuin Poh; Elad Sintov; Mads Gürtler; Felicia W Pagliuca; Quinn P Peterson; Douglas A Melton
Journal:  Nature       Date:  2019-05-08       Impact factor: 49.962

5.  Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells.

Authors:  Ryan Lister; Mattia Pelizzola; Yasuyuki S Kida; R David Hawkins; Joseph R Nery; Gary Hon; Jessica Antosiewicz-Bourget; Ronan O'Malley; Rosa Castanon; Sarit Klugman; Michael Downes; Ruth Yu; Ron Stewart; Bing Ren; James A Thomson; Ronald M Evans; Joseph R Ecker
Journal:  Nature       Date:  2011-02-02       Impact factor: 49.962

6.  Post-natal cardiomyocytes can generate iPS cells with an enhanced capacity toward cardiomyogenic re-differentation.

Authors:  R Rizzi; E Di Pasquale; P Portararo; R Papait; P Cattaneo; M V G Latronico; C Altomare; L Sala; A Zaza; E Hirsch; L Naldini; G Condorelli; C Bearzi
Journal:  Cell Death Differ       Date:  2012-01-20       Impact factor: 15.828

7.  Genetic background drives transcriptional variation in human induced pluripotent stem cells.

Authors:  Foad Rouhani; Natsuhiko Kumasaka; Miguel Cardoso de Brito; Allan Bradley; Ludovic Vallier; Daniel Gaffney
Journal:  PLoS Genet       Date:  2014-06-05       Impact factor: 5.917

8.  A comparison of genetically matched cell lines reveals the equivalence of human iPSCs and ESCs.

Authors:  Jiho Choi; Soohyun Lee; William Mallard; Kendell Clement; Guidantonio Malagoli Tagliazucchi; Hotae Lim; In Young Choi; Francesco Ferrari; Alexander M Tsankov; Ramona Pop; Gabsang Lee; John L Rinn; Alexander Meissner; Peter J Park; Konrad Hochedlinger
Journal:  Nat Biotechnol       Date:  2015-10-26       Impact factor: 54.908

9.  Acquisition of Dynamic Function in Human Stem Cell-Derived β Cells.

Authors:  Leonardo Velazco-Cruz; Jiwon Song; Kristina G Maxwell; Madeleine M Goedegebuure; Punn Augsornworawat; Nathaniel J Hogrebe; Jeffrey R Millman
Journal:  Stem Cell Reports       Date:  2019-01-17       Impact factor: 7.765

10.  Genes Associated with Pancreas Development and Function Maintain Open Chromatin in iPSCs Generated from Human Pancreatic Beta Cells.

Authors:  Matthias Thurner; Liraz Shenhav; Agata Wesolowska-Andersen; Amanda J Bennett; Amy Barrett; Anna L Gloyn; Mark I McCarthy; Nicola L Beer; Shimon Efrat
Journal:  Stem Cell Reports       Date:  2017-11-01       Impact factor: 7.765

View more
  2 in total

Review 1.  Organoids and microphysiological systems: Promising models for accelerating AAV gene therapy studies.

Authors:  Ritu Mahesh Ramamurthy; Anthony Atala; Christopher D Porada; Graҫa Almeida-Porada
Journal:  Front Immunol       Date:  2022-09-26       Impact factor: 8.786

Review 2.  Monogenic Diabetes Modeling: In Vitro Pancreatic Differentiation From Human Pluripotent Stem Cells Gains Momentum.

Authors:  Juan Ignacio Burgos; Ludovic Vallier; Santiago A Rodríguez-Seguí
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-06       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.